| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |